Revision: Jan. 29, 2026, 1:47 p.m.
Sen. Gannon, Dist 23
January 23, 2026
2026-0258s
05/07
Floor Amendment to SB 400
Amend RSA 126-X:12, IV(a) as inserted by section 1 of the bill by replacing it with the following:
(a) Biennially reviewing medical and scientific evidence pertaining to currently approved and additional qualifying conditions.
2026-0258s
AMENDED ANALYSIS
This bill requires the therapeutic cannabis medical oversight board to biennially review medical and scientific evidence relative to currently approved and additional qualifying conditions. The bill also requires the board's annual report to include citations to such medical and scientific evidence.